MSF's publications are an expression of our belief in the principle of témoignage, or bearing witness, and the belief that we are accountable to those we work for and with. Sharing news about our activities and reflecting on them, offering critiques when necessary, are therefore crucial aspects of our work.

View and download these publications below.

To view the U.S. Annual Reports or International Activity Reports, please visit the Annual Reports page.

Over the past half century, there have been unprecedented improvements in health outcomes, spurred in part by unparalleled scientific progress in the pharmaceutical sector. Yet access to the benefits of medical progress and scientific advancement has not been equitably shared and many innovation gaps remain.

More >

Despite recent advances, there's still a need to make noise about "the silent disease."

More >

In this op-ed Dr. Unni Karunakara, international president of MSF, calls for increased commitment to the elimination of neglected diseases.

More >

Chagas disease, or American trypanosomiasis, is a parasitic disease caused by Trypanosoma cruzi (T. cruzi) and is transmitted mainly by insects called triatomines, also known as ‘assassin bugs’ or ‘kissing bugs’. It is endemic in 21 Latin American countries and cases have also been reported in the U.S., Europe, and Japan.

More >

Innovation and Access for Neglected Diseases: The Experience of Médecins Sans Frontières

U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP) Hearing

Oral Statement of
Suerie Moon
Board of Directors
Doctors Without Borders/Médecins Sans Frontières - USA
July 21, 2010, 10am
430 Dirksen Senate Office Building

Thank you, Chairperson Harkin, Ranking Member Enzi, and the Committee.

More >

By Dr. Unni Karunakara, incoming president of MSF's International Council, and Dr. Bernard Pecoul, executive director of the Drugs for Neglected Diseases initiative

More >

Over 1 billion people are infected with one of the 14 diseases defined by the World Health Organization (WHO) as neglected tropical diseases (NTDs). These are the most common infections in the 2.7 billion people living on less than $2 a day and affects those often marginalized and forgotten by governments, left to suffer in silence. NTDs are diverse but all cause severe disability or death, and bring a major economic burden on endemic countries.

More >

Opportunities to Expand the U.S. Impact


More >

Statement by Sophie Delaunay Executive Director, MSF-USA

This annual Ministerial review focusing on philanthropy and the Global Health Agenda clearly shows recognition of the urgency to address global health challenges. However, this initiative cannot replace the critical need for greater government leadership to stimulate medical innovation for neglected diseases affecting millions in the poorest corners of the world.

More >

This is a transcript of Dr. Rockefeller's extemporaneous remarks on May 15 before the Congressional Human Rights Caucus and the Congressional Black Caucus Health Brain Trust on access to medicines.

More >

Pages